Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(4-phenylamino-quinazolin-6-yl)-acrylamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-(4-phenylamino-quinazolin-6-yl)-acrylamide is an experimental small molecule belonging to the quinazolinamine class of organic compounds. It has not been approved for use in any country and is not currently in clinical trials beyond preclinical or early research phases. The compound's mechanism of action involves inhibition of the proto-oncogene tyrosine-protein kinase Src, a non-receptor tyrosine kinase implicated in cancer cell proliferation and survival. Its primary research interest lies in oncology as a potential targeted therapy, but no specific developer or manufacturer is listed, and there are no known brand names or marketed formulations[1][2].
- Other names
- N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
02
Targets
SRC (Proto-oncogene tyrosine-protein kinase Src)EGFR (Epidermal growth factor receptor)
Beyond the preview
Go deeper on N-(4-phenylamino-quinazolin-6-yl)-acrylamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(4-phenylamino-quinazolin-6-yl)-acrylamide.